pravastatin has been researched along with Amentia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clifton, J; Lang, T; Neher, J; Safranek, S | 1 |
| de Haan, S; Ford, I; Jukema, JW; Rostamian, S; Sabayan, B; van Buchem, MA; van der Grond, J | 1 |
| Catapano, AL; Corrao, G; Ibrahim, B; Mancia, G; Merlino, L; Nicotra, F; Pasini, TS; Zambon, A | 1 |
| Bullock, R; Craig, D; McGuinness, B; Passmore, P | 2 |
| de Craen, AJ; Lingsma, HF; Mooijaart, SP; Nieboer, D; Richard, E; Steyerberg, EW; van Leeuwen, N | 1 |
| Darvesh, S; Martin, E; Rockwood, K; Walsh, R | 1 |
| Feinberg, AW | 1 |
| Kast, RE | 1 |
2 review(s) available for pravastatin and Amentia
| Article | Year |
|---|---|
Statins for the prevention of dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Anticholesteremic Agents; Cognition; Dementia; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Simvastatin | 2016 |
Statins for the prevention of dementia.
Topics: Alzheimer Disease; Anticholesteremic Agents; Cognition; Dementia; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Randomized Controlled Trials as Topic; Simvastatin | 2009 |
1 trial(s) available for pravastatin and Amentia
| Article | Year |
|---|---|
Cognitive Function in Dementia-Free Subjects and Survival in Old Age: The PROSPER Study.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Cerebrovascular Circulation; Cognition; Dementia; Executive Function; Female; Geriatric Assessment; Humans; Internationality; Magnetic Resonance Imaging; Male; Memory; Multivariate Analysis; Neuropsychological Tests; Pravastatin; Proportional Hazards Models; Prospective Studies; Survival Analysis | 2019 |
6 other study(ies) available for pravastatin and Amentia
| Article | Year |
|---|---|
Clinical Inquiries. Do statins alter the risk or progression of dementia?
Topics: Adult; Aged; Aged, 80 and over; Cognition; Dementia; Disease Progression; Female; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Simvastatin; United States; United States Food and Drug Administration | 2018 |
Long-term use of statins reduces the risk of hospitalization for dementia.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Case-Control Studies; Dementia; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Italy; Logistic Models; Male; Middle Aged; Pravastatin; Pyrroles; Risk; Simvastatin; Time Factors | 2013 |
Regression Discontinuity Design: Simulation and Application in Two Cardiovascular Trials with Continuous Outcomes.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cardiovascular Diseases; Cholesterol; Computer Simulation; Coronary Disease; Dementia; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Male; Monte Carlo Method; Pravastatin; Randomized Controlled Trials as Topic; Regression Analysis; Reproducibility of Results; Research Design; Risk Reduction Behavior; Statistics as Topic | 2016 |
Differential effects of lipid-lowering agents on human cholinesterases.
Topics: Cholinesterase Inhibitors; Clinical Trials as Topic; Cohort Studies; Dementia; Humans; Hypolipidemic Agents; Lovastatin; Molecular Structure; Pravastatin; Simvastatin | 2004 |
Statins & Alzheimer's.
Topics: Aged; Alzheimer Disease; Anticholesteremic Agents; Dementia; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Middle Aged; Pravastatin | 2000 |
Dementia and statins.
Topics: Aged; Aged, 80 and over; Dementia; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Middle Aged; Pravastatin; Tumor Necrosis Factor-alpha | 2001 |